Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131836) titled 'Sphingolipid Metabolic Reprogramming Drives the JUN-RAC1 Signaling Axis in Brain Metastasis of EGFR-Mutant Lung Adenocarcinoma' on Sept. 7.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Chongqing University Three Gorges Hospital(Chongqing Three Gorges Central Hospital)
Condition:
EGFR-mutated lung adenocarcinoma with brain metastasis
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-07
Target Sample Size: The group with brain metastasis from lung cancer and the group without brain metastasis from lung cancer:60;
Countries of Recruitment:
C...